Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Obstet Anesth ; 23(4): 302-8, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25281438

RESUMO

BACKGROUND: Pain is a common distressing adverse effect in the early postoperative period following caesarean section. The aim of this study was to investigate the effect on postoperative pain, analgesic requirement and haemodynamic profile of placing a suprafacial bupivacaine-soaked absorbable gelatin sponge in the caesarean section wound. METHODS: A total of 164 healthy patients scheduled to undergo general anaesthesia for elective caesarean section were randomised to a study group (n=81) or a control group (n=83). In the study group, a bupivacaine-soaked absorbable gelatin sponge was placed subcutaneously in the caesarean section wound. Intramuscular diclofenac 75 mg was given to all patients at 8-h intervals during the first 24h. Postoperatively, visual analogue scale pain scores, requirement for pethidine and diclofenac and changes in blood pressure and heart rate were compared between groups. RESULTS: Pain scores were lower in the study group compared to the control group at all assessments (P<0.001). During the first eight hours after surgery, fewer patients in the study group required rescue pethidine compared with the control group (4 vs. 33, P<0.001). In the study group, total opioid and diclofenac consumption was lower (P<0.001), and blood pressure and heart rate were lower (P<0.001) compared to the control group. CONCLUSION: Suprafascial wound placement of a bupivacaine-soaked absorbable gelatin sponge improved postoperative analgesia and decreased opioid consumption following caesarean section.


Assuntos
Analgésicos/uso terapêutico , Anestésicos Locais/administração & dosagem , Bupivacaína/administração & dosagem , Cesárea/métodos , Esponja de Gelatina Absorvível/uso terapêutico , Hemodinâmica/efeitos dos fármacos , Dor Pós-Operatória/tratamento farmacológico , Administração Tópica , Adolescente , Adulto , Analgésicos/administração & dosagem , Anestesia Obstétrica/métodos , Anestésicos Locais/efeitos adversos , Anestésicos Locais/uso terapêutico , Bupivacaína/efeitos adversos , Bupivacaína/uso terapêutico , Método Duplo-Cego , Feminino , Gelatina , Humanos , Medição da Dor/efeitos dos fármacos , Gravidez , Estudos Prospectivos , Fatores Socioeconômicos , Adulto Jovem
2.
J Obstet Gynaecol ; 34(6): 476-8, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24766260

RESUMO

To assess the association of polymorphisms of toll-like receptors (TLRs) 2, 3 and 4 with the delay in onset of labour at term pregnancies, patients delivering at > 37 weeks and without pre-eclampsia, IUGR or a history of preterm delivery were prospectively evaluated. TLR2 Arg753Gln, TLR3 (c.1377C/T) and TLR4 Asp299Gly and Thr399Ile polymorphisms were genotyped by using PCR-RFLP. Patients labouring spontaneously before the 41st week were compared with those who did not labour spontaneously until this week in terms of baseline characteristics, TLR 2, 3 and 4 polymorphisms. The same comparisons were also performed by using a 40th week cut-off. Chi-square test, two-sample t-test or Mann-Whitney U tests were used for comparisons, as appropriate. In total, 79 patients delivering after 37 weeks were evaluated. All had CC genotype for TLR2 Arg753Gln and TLR4 Thr399Ile. There were no significant differences for TLR4 Asp299Gly GA and TLR3 (c.1377C/T) polymorphisms between patients spontaneously entering or not entering labour until the 41st week; the same was true when the 40th week cut-off was used. Delay in onset of labour at term pregnant women does not seem to be affected by the presence of TLR 2, 3 or 4 polymorphisms. Further studies are needed.


Assuntos
Trabalho de Parto/genética , Receptores Toll-Like/genética , Adulto , Substituição de Aminoácidos , Feminino , Humanos , Trabalho de Parto Induzido , Gravidez , Estudos Prospectivos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...